Webinar

The role of the Gut Microbiome for Drug Response

WEBINAR: The role of the Gut Microbiome for Drug Response

Varying drug response is a key factor in both drug development and clinical practice and result in sub-optimal treatment and failed clinical trials.

Resent years research has detailed how the gut microbiome plays an essential role for drug response, and how the inter-individual variation in the composition of the gut microbiome is an important factor, both in drug trials and treatment.

Elements in the webinar

In this seminar, we will dive into this interesting topic, and take you through

  • Key research into how the microbiome can affect drug response
  • How microbiome profiling of patients can be used to gain insight and control in clinical trials at all stages,
  • How microbiome profiling can be used to detect a novel type of biomarkers.

Biomcare is providing sampling support, sequencing, and data analysis for the microbiome aspects of the large NORDIC-SUN clinical trial of Immune Checkpoint Inhibitors, and we will finish the seminar by introducing this project and our solution for microbiome analysis in clinical studies and trials.

Time: 25. January 3pm CET

Location: Online

 Duration: 1 hour

Price: Free

Seats: 100!

Level: Basic understanding of drug response/clinical studies is an advantage

100 seats limit. Sign-up below.

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Time: 25. January 3pm CET

Location: Online

 Duration: 1 hour

Price: Free

Seats: 100!

Level: Basic understanding of drug response/clinical studies is an advantage

Your webinar hosts:

Louise Bruun Thingholm

Louise Bruun Thingholm

CEO Biomcare | Ph.D. in Bioinformatics | Chief Scientific Officer

Anne Mathiesen

Anne Mathiesen

Bioinformatics Scientist | MSc in microbiome bioinformatics